不同损器械的有效性和安全性的差异
Yukako Ogoyama1, Kazuomi Kario2
1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan. 99015yo@jichi.ac.jp.
概括
脏缩 (RDN) 是一种对抗性高血压的微创治疗方法. 最近的进展和FDA对射频和超声波设备的批准显示了这种治疗的新希望.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 脏消毒 (RDN) 是一种使用消毒的内血管程序,用于治疗耐药高血压.
- 在HTN-3试验之后,最初的热情逐渐减弱,导致设备开发停止.
- 最近的试验和改进的研究设计使人们对RDN的兴趣重新获得活力.
研究的目的:
- 审查和比较不同RDN器件的抗高血压作用和安全性.
- 分析无线电频率,超声波和酒精介导的RDN的程序终点.
- 为未来的脏剥皮技术的开发和应用提供信息.
主要方法:
- 对现有的随机对照试验和关于RDN设备的已公布数据的审查.
- 基于剥离方式的手术结果分析:射频,超声波和酒精介导.
- 安全性和有效性终点的比较,包括门诊和办公室血压测量.
主要成果:
- 美国FDA于2023年11月批准了射频和超声波RDN设备.
- 已公布的试验结果存在于酒精介导的RDN设备.
- 分析显示,RDN设备类型与降血压之间没有显著的相互作用.
结论:
- 包括射频和超声波在内的脏剥皮装置正在获得监管部门的批准.
- 持续的研究和设备改进对于优化RDN治疗至关重要.
- 需要进一步评估不同的RDN模式,以确定它们的比较有效性.
更多相关视频
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.1K
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
Antihypertensive Drugs: Direct Renin Inhibitors
538
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
538
